These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 18541623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial.
    Verster JC, Bekker EM, de Roos M, Minova A, Eijken EJ, Kooij JJ, Buitelaar JK, Kenemans JL, Verbaten MN, Olivier B, Volkerts ER.
    J Psychopharmacol; 2008 May; 22(3):230-7. PubMed ID: 18308788
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [Abstract] [Full Text] [Related]

  • 6. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun 19; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
    Taéron C.
    Rev Infirm; 2009 Jun 19; (151):47-9. PubMed ID: 19579855
    [No Abstract] [Full Text] [Related]

  • 9. Methylphenidate significantly reduces lapses of attention during on-road highway driving in patients with ADHD.
    Verster JC, Roth T.
    J Clin Psychopharmacol; 2014 Oct 19; 34(5):633-6. PubMed ID: 24978156
    [Abstract] [Full Text] [Related]

  • 10. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar 23; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Question 2 Should a child with ADHD and epilepsy be given ritalin?
    Boyes C.
    Arch Dis Child; 2010 Sep 23; 95(9):759-61. PubMed ID: 20716679
    [No Abstract] [Full Text] [Related]

  • 15. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M, Uekermann J, Wiltfang J, Kis B.
    Clin Neuropharmacol; 2010 Jul 23; 33(4):204-6. PubMed ID: 20571380
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Visual fields in children with attention-deficit/hyperactivity disorder before and after treatment with stimulants.
    Ghanizadeh A.
    Acta Ophthalmol; 2010 Mar 23; 88(2):e56. PubMed ID: 19508459
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.
    J Clin Psychopharmacol; 2009 Jun 23; 29(3):239-47. PubMed ID: 19440077
    [Abstract] [Full Text] [Related]

  • 20. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M.
    Pediatrics; 2007 Jan 23; 119(1):154-5. PubMed ID: 17200281
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.